Skip to Main Content

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. 

A boom in breakthroughs


The Food and Drug Administration’s authorizations for innovative devices have significantly accelerated this year, green lighting 11 of its 54 authorized “breakthrough devices” — as many as in all of 2020. The FDA deems “breakthrough devices” as potentially able to offer “more effective” treatment or diagnosis for deadly and debilitating conditions. But until this year, relatively few of the nearly 700 products labeled as such have reached the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.